JP2016020396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016020396A5 JP2016020396A5 JP2015215222A JP2015215222A JP2016020396A5 JP 2016020396 A5 JP2016020396 A5 JP 2016020396A5 JP 2015215222 A JP2015215222 A JP 2015215222A JP 2015215222 A JP2015215222 A JP 2015215222A JP 2016020396 A5 JP2016020396 A5 JP 2016020396A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- ion channel
- fragment
- binds
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004965 antibodies Human genes 0.000 claims 13
- 108090001123 antibodies Proteins 0.000 claims 13
- 102000004310 Ion Channels Human genes 0.000 claims 12
- 108090000862 Ion Channels Proteins 0.000 claims 12
- 239000011734 sodium Substances 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 102000018674 Sodium Channels Human genes 0.000 claims 1
- 108010052164 Sodium Channels Proteins 0.000 claims 1
- 238000004166 bioassay Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
Claims (6)
前記イオンチャネルが疼痛の調節において機能し、前記抗体又は断片が前記イオンチャネルを、それに結合した後、機能的に改変し;
イオンチャネルが、Na v 1.3、1.6、1.8、及び1.9からなる群から選択されるナトリウムイオンチャネルであり;
イオンチャネルのドメインB又はドメインCにおけるE1ループに結合する上記抗体又はその結合断片。 An anti-E1 ion channel antibody or binding fragment thereof that binds to the E1 extracellular loop of an ion channel, comprising:
The ion channel functions in the regulation of pain, and the antibody or fragment functionally modifies after binding the ion channel to the ion channel ;
The ion channel is a sodium ion channel selected from the group consisting of Na v 1.3, 1.6, 1.8, and 1.9;
The antibody or the binding fragment thereof, which binds to the E1 loop in domain B or domain C of the ion channel .
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25520209P | 2009-10-27 | 2009-10-27 | |
US61/255,202 | 2009-10-27 | ||
GB0922434.6 | 2009-12-22 | ||
GBGB0922434.6A GB0922434D0 (en) | 2009-12-22 | 2009-12-22 | antibodies and fragments thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012535812A Division JP5872476B2 (en) | 2009-10-27 | 2010-10-27 | Antibodies against ion channels |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016020396A JP2016020396A (en) | 2016-02-04 |
JP2016020396A5 true JP2016020396A5 (en) | 2016-05-19 |
JP6335152B2 JP6335152B2 (en) | 2018-05-30 |
Family
ID=55265454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015215222A Expired - Fee Related JP6335152B2 (en) | 2009-10-27 | 2015-10-30 | Antibodies against ion channels |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6335152B2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7195879B2 (en) * | 2002-04-12 | 2007-03-27 | Ortho-Mcneil Pharmaceutical, Inc. | Method for identifying modulators of NAv ion channels |
GB0517487D0 (en) * | 2005-08-26 | 2005-10-05 | Isis Innovation | Antibodies |
-
2015
- 2015-10-30 JP JP2015215222A patent/JP6335152B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017048194A5 (en) | ||
JP2018504907A5 (en) | ||
PE20191551A1 (en) | DESIGNED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES | |
RU2018132044A (en) | ANTIBODIES AGAINST TAU | |
MX2020013058A (en) | Monovalent blood brain barrier shuttle modules. | |
EA201792245A1 (en) | BIOCONJUGATES AND THEIR APPLICATIONS | |
BR112015022978A8 (en) | multimerization technologies | |
RU2021134101A (en) | MODIFIED J-CHAIN | |
JP2014518898A5 (en) | ||
WO2015143123A3 (en) | Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof | |
AR082149A1 (en) | ANTIBODIES AGAINST HUMAN RESPIRATORY SYNTHETIC VIRUS (RSV) AND METHODS FOR USE | |
UA111818C2 (en) | ANTIBODY AGAINST CSF-1R | |
PH12015501505B1 (en) | Antibodies that bind to tl1a and their uses | |
JP2013539454A5 (en) | ||
CY1122132T1 (en) | METHODS OF REDUCING ASTHMA FLASH RATE USING BENRALIZUMAB | |
IN2014CN04498A (en) | ||
JP2016509011A5 (en) | ||
MY192113A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment of anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition | |
MX2016004579A (en) | Tm4sf1 binding proteins and methods of using same. | |
NZ629553A (en) | Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof | |
JP2018504911A5 (en) | ||
UA108778C2 (en) | ANTI-CANCER Fusion PROTEIN | |
PH12017500699A1 (en) | Antibodies that bind to ccr6 and their uses | |
WO2015107363A3 (en) | Mycobacterial antigen composition | |
EP4269562A3 (en) | Antigen binding molecules and methods of use thereof |